Man­u­fac­tur­ing roundup: Phar­maron se­cures ac­qui­si­tion of a Rhode Is­land fa­cil­i­ty; GSK to open hub in South Amer­i­ca

A Chi­nese phar­ma com­pa­ny is grow­ing its pres­ence in the US with a new­ly ac­quired API man­u­fac­tur­ing site.

Phar­maron has en­tered in­to a de­fin­i­tive agree­ment to ac­quire a Coven­try, Rhode Is­land-based API man­u­fac­tur­ing site from drug man­u­fac­tur­er No­ram­co, which was pre­vi­ous­ly owned by John­son & John­son and now owned by the pri­vate eq­ui­ty firm SK Cap­i­tal.

Ac­cord­ing to Phar­maron, the site has an es­tab­lished his­to­ry of API man­u­fac­tur­ing from pi­lot kilo­gram to com­mer­cial met­ric ton scales. How­ev­er, ac­cord­ing to The Peo­ple’s Ra­dio, an NPR sta­tion cov­er­ing Rhode Is­land and parts of Mass­a­chu­setts, the fa­cil­i­ty was for­mer­ly owned by a sub­sidiary of Pur­due Phar­ma­ceu­ti­cals called Rhodes Tech­nolo­gies and was known for mak­ing opi­oid prod­ucts. Ac­cord­ing to that re­port, be­cause of Pur­due’s 2019 bank­rupt­cy fil­ing, the Coven­try fac­to­ry was sold to No­ram­co, an­oth­er opi­oid in­gre­di­ent man­u­fac­tur­er.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.